How Do You Treat Immersion Foot Injury?
Discussion All occupations have some type of potential health consequences. Some are obvious because of the environment such as kitchen workers, first responders, helicopter pilots, etc. Others are may be less obvious or not considered such as slip and falls, cleaning supply chemical exposure, animal bites for postal and utility workers, etc. Noise and lifting objects are often overlooked problems in some settings but obvious in others such as construction. Protective measures, especially appropriate education and training and protective clothing and safety gear are obviously important for performing the work as safely as ...
Source: PediatricEducation.org - July 26, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Face Mask-Related Injuries Rose Dramatically in 2020 Face Mask-Related Injuries Rose Dramatically in 2020
Dermatitis was the most common mask-related injury treated last year.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 23, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Proposed Classification Framework for Atopic Dermatitis Unveiled Proposed Classification Framework for Atopic Dermatitis Unveiled
Goals include standardizing the assessment of AD in clinical practice and making it easier to tailor therapy to individual patient characteristics.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 16, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Incidence of occupational contact dermatitis in healthcare workers: a systematic review
Healthcare workers (HCWs) can be considered at an increased risk of developing occupational contact dermatitis (OCD) due to repetitive hand washing with soaps and disinfectants and extended use of gloves for many hours during the day. The aim of this study was to summarize the incidence of OCD in HCWs. We searched the databases PubMed/MEDLINE (1980-present), EMBASE (1980-present) and Cochrane Library (1992-present) through May 2020 using the search term'incidence of contact dermatitis in HCWs'according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Overall, 16 studies (six cohort...
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Questionnaire Responses About Dermatology History Inconsistent
TUESDAY, July 13, 2021 -- Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2021 Category: Pharmaceuticals Source Type: news

DR ELLIE CANNON: Will I have itchy red spots on my feet for the rest of my life?
DR ELLIE CANNON: In most cases like this, it is a flare-up of a skin condition called dermatitis, although another cause of an irritating rash can be an inflammatory condition (file photo pictured). (Source: the Mail online | Health)
Source: the Mail online | Health - July 3, 2021 Category: Consumer Health News Source Type: news

Survey Spotlights the Out-of-Pocket Burden on Blacks With Atopic Dermatitis Survey Spotlights the Out-of-Pocket Burden on Blacks With Atopic Dermatitis
The clinical phenotype and burden of AD can vary across racial and ethnic groups, according to the investigator.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 28, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

What Triggers Seborrheic Dermatitis Symptoms
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

Hand Hygiene Habits and Prevalence of Hand Eczema During the COVID-19 Pandemic
Conclusion: In terms of hand eczema prevention, we suggest that the use of alcohol-based products should be discontinued if other handwashing methods are available. The following factors increase the risk of hand eczema: being a HCW, having previous hand eczema, and having underlying atopic dermatitis. Proper strategies in terms of hand eczema prevention should be addressed, especially in this group, since we need to continue performing hand hygiene during the ongoing COVID-19 pandemic. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2021 Category: Consumer Health News Source Type: news

Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis
WILMINGTON, Del.--(BUSINESS WIRE) June 11, 2021 -- Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for ruxolitinib cream for the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 11, 2021 Category: Drugs & Pharmacology Source Type: news

What Are Some Indications for Using Dexamethasone?
Discussion Corticosteroids are a group of drugs which can be naturally or synthetically produced. Naturally occurring substances are produced in the adrenal gland, and are protein-bound (primarily corticosteroid-binding globulin and albumin). In the target tissues, they may need to be converted to an active substance. They are then reduced, oxidized, hydroxylated or conjugated as measures to inactivate them. Synthetic steroids have less protein binding and depending on their structure are more or less resistant to inactivation. Prednisone is the glucocorticoid most often used for treatment, especially as it has a short hal...
Source: PediatricEducation.org - June 7, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A ...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
Agreement Renews Successful Global Collaboration That led to Several Groundbreaking Therapies in Multiple Disease Areas KHK4083 Depletes OX40-Expressing T cells Associated with Atopic Dermatitis and Several Other Inflammatory Diseases Moderate-to-Sev... Biopharmaceuticals, Dermatology Amgen, Kyowa Kirin, atopic dermatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2021 Category: Pharmaceuticals Source Type: news

Rare Intervention for Incontinence-Associated Dermatitis Rare Intervention for Incontinence-Associated Dermatitis
In this article, two rare cases of incontinence-associated dermatitis that presented as chemical burns are discussed. How were these patients managed?Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 28, 2021 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of RYBREVANTTM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.[1] RYBREVANTTM is the first fully-human, bispecific antibody approved for the treatment of patients with NSCLC t...
Source: Johnson and Johnson - May 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
FRIDAY, May 21, 2021 -- Upadacitinib shows short-term efficacy for moderate-to-severe atopic dermatitis in adolescents and adults, according to a study published online May 20 in The Lancet. Emma Guttman-Yassky, M.D., from the Icahn School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 21, 2021 Category: Pharmaceuticals Source Type: news

Pivotal results from Trinity clinical trial for the chronic condition atopic dermatitis
(Trinity College Dublin) Trinity College Dublin and St James's Hospital, Dublin clinical trials reported efficacy and safety results of upadacitinib compared with placebo for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents. This pivotal Global Phase 3 study involved 1,600 patients and took place over a two-year period. Results show the drug to so far be the most effective treatment for atopic dermatitis in clinical trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 21, 2021 Category: International Medicine & Public Health Source Type: news

Updated Amivantamab and Lazertinib Combination Data Demonstrate Durable Responses and Clinical Activity for Osimertinib-Relapsed Patients with EGFR-Mutated Non-Small Cell Lung Cancer
May 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated data from the Phase 1 CHRYSALIS study showing treatment with amivantamab in combination with lazertinib led to a median duration of response (DOR) of 9.6 months in chemotherapy-naïve patients with non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib.[1] These data, which will be presented in an oral presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual ...
Source: Johnson and Johnson - May 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Internet-Delivered CBT Reduces Atopic Dermatitis Symptoms
WEDNESDAY, May 19, 2021 -- Internet-delivered cognitive behavior therapy (CBT) reduces symptoms of atopic dermatitis, according to a study published online May 19 in JAMA Dermatology. Erik Hedman-Lagerlöf, Ph.D., from the Karolinska Institutet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 19, 2021 Category: Pharmaceuticals Source Type: news

Photoprotection Recommended for People of Color Photoprotection Recommended for People of Color
Photoprotection for people of color helps minimize the development of photodermatoses, postinflammatory hyperpigmentation, polymorphous light eruption, and chronic actinic dermatitis.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - May 17, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Spontaneous Resolution of Atopic Dermatitis With Benralizumab Spontaneous Resolution of Atopic Dermatitis With Benralizumab
This patient experienced spontaneous resolution of atopic dermatitis while participating in a trial of benralizumab for severe asthma, highlighting the potential shared mechanisms of these conditions.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 13, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis
THURSDAY, May 13, 2021 – Baricitinib demonstrates sustained long-term efficacy in patients with moderate-to-severe atopic dermatitis, according to a study published online May 12 in JAMA Dermatology. Jonathan I. Silverberg, M.D., from the George... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2021 Category: Pharmaceuticals Source Type: news

Hand Dermatitis Currently Prevalent in Health Care Workers
Prevalence of hand dermatitis 92.6 percent in health care workers, 68.7 percent for general population (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 12, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Hand Dermatitis Currently Prevalent in Health Care Workers
WEDNESDAY, May 12, 2021 -- More than 90 percent of health care workers and two-thirds of the general population currently have hand dermatitis, according to a study presented at the European Academy of Dermatology and Venereology Spring Symposium,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 12, 2021 Category: Pharmaceuticals Source Type: news

Early-Life Exposure to Antibiotics Linked to Atopic Dermatitis
TUESDAY, May 4, 2021 -- Exposure to antibiotics in utero and during the first year of life is associated with an increased risk for atopic dermatitis, with the correlation partially attenuated after adjustment for familial factors, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Emollient Data Discouraging for Atopic Dermatitis Prevention Emollient Data Discouraging for Atopic Dermatitis Prevention
Emollients did not appear to prevent atopic dermatitis in a trial of babies at high risk for the disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 3, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

ICER issues draft report on atopic dermatitis treatments for moderate-to-severe disease
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2021 Category: Drugs & Pharmacology Source Type: news

How much does it itch?
(Northwestern University) Itch can be as debilitating as chronic pain. But it's a hard symptom to measure -- particularly for the 10 million U.S. children with atopic dermatitis, also known as eczema. But now there is a soft, wearable sensor that quantifies itch by measuring scratching when placed on the hand. It allows parents and doctors to track how well itch is being controlled in patients, monitor treatment response and early signs of worsening disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 30, 2021 Category: Cancer & Oncology Source Type: news

Atopic Dermatitis Genes Vary With Ethnicity Atopic Dermatitis Genes Vary With Ethnicity
Koreans with atopic dermatitis don't share the same genetic biomarkers as other populations studied so far.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 29, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Wildfire Air Pollution Tied to Uptick in Visits for Dermatitis, Itch
TUESDAY, April 27, 2021 -- Short-term exposure to air pollution due to a wildfire is associated with increased health care use for patients with atopic dermatitis and itch, according to a study published online April 21 in JAMA Dermatology. Raj P.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2021 Category: Pharmaceuticals Source Type: news

Multidisciplinary Approach Touted for Atopic Dermatitis Multidisciplinary Approach Touted for Atopic Dermatitis
Patients with atopic dermatitis benefit when dermatologists, allergists, and pharmacists work together on treatment plans.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Tralokinumab Gets Nod for Atopic Dermatitis in Europe Tralokinumab Gets Nod for Atopic Dermatitis in Europe
The new opinion represents the final stages before the European Commission decides whether tralokinumab will be authorized for use throughout the European Union.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 23, 2021 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news

Upadacitinib Clears Atopic Dermatitis Faster Than Dupilumab Upadacitinib Clears Atopic Dermatitis Faster Than Dupilumab
A new JAK1 inhibitor provided greater symptom relief than dupilumab in an atopic dermatitis trial.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 23, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Arena Pharmaceuticals presents clinician and patient reported outcomes data from phase 2b ADVISE trial evaluating etrasimod in adult atopic dermatitis during a late-breaking session at American Academy of Dermatology VMX
(LaVoieHealthScience) Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced data at a late-breaking session at the American Academy of Dermatology VMX Experience. Etrasimod, a novel investigational drug candidate to treat moderate-to-severe atopic dermatitis (AD), demonstrated statistical significance in both clinician and patient reported outcomes in the ADVISE Phase 2b clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 23, 2021 Category: International Medicine & Public Health Source Type: news

TARC Identifies Poor Dupilumab Response in Atopic Dermatitis TARC Identifies Poor Dupilumab Response in Atopic Dermatitis
Serum thymus and activation-regulated chemokine (TARC) levels may pinpoint a category of atopic dermatitis cases needing the most intensive dupilumab treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 22, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Latest remedy for eczema - rub bacteria on to your skin! 
Studies suggest a healthy strain of skin bacteria can effectively treat flare-ups in people with the most common form of eczema, called atopic dermatitis, which affects 15 million people in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2021 Category: Consumer Health News Source Type: news

Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities
Findings independent of socioeconomic characteristics, onset age, and other related disorders (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 15, 2021 Category: Psychiatry Tags: Dermatology, Family Medicine, Neurology, Pediatrics, Psychiatry, Journal, Source Type: news

Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities
THURSDAY, April 15, 2021 -- Worse atopic dermatitis (AD) severity is associated with increased odds of learning disorders in pediatric patients, according to a study published online April 14 in JAMA Dermatology. Joy Wan, M.D., from the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2021 Category: Pharmaceuticals Source Type: news

Drug giant Eli Lilly bought an emerging Peninsula skin drug company last year — here's what's left of it
A blockbuster atopic dermatitis drug is moving closer to an FDA decision, another is rolling up into an Arizona company, another Bay Area company is launching, a Peninsula site is closing and 163 jobs are getting cut. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 12, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for the Treatment of Moderate to Severe Atopic Dermatitis
NEW YORK--(BUSINESS WIRE) April 07, 2021 -- Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 7, 2021 Category: Drugs & Pharmacology Source Type: news

Contact Dermatitis Content Varies Among Social Media Sites Contact Dermatitis Content Varies Among Social Media Sites
Data on social media use suggest that approximately 65% of US adults regularly use social media, and 40% use it when making medical decisions.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 1, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Tralokinumab for Atopic Dermatitis: A Promising New Therapy Tralokinumab for Atopic Dermatitis: A Promising New Therapy
Multiple trials of tralokinumab, an interleukin-13 inhibitor, indicate that it is a promising treatment option for patients with moderate-to-severe atopic dermatitis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Self-inflicted dermatoses in adolescence: a case series - Sarti L, Fusco E, Oranges T, Nocentini S, Giovannini M, Liccioli G, Barni S, Martin R, Mori F, Filippeschi C.
We describe three teenagers referred to Meyer Children's University Hospital with unusual rashes. A 14‐year‐old girl (case 1) was referred to the Allergy Unit with suspected Stevens‐Johnso... (Source: SafetyLit)
Source: SafetyLit - March 29, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Itch Response Faster With Abrocitinib Compared to Dupilumab Itch Response Faster With Abrocitinib Compared to Dupilumab
An experimental oral Janus kinase 1 (JAK1) inhibitor, abrocitinib, showed greater itch reduction after 2 weeks of treatment than dupilumab in patients with moderate to severe atopic dermatitis, in a multicenter, randomized trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news

Abrocitinib Bests Placebo for Treatment of Atopic Dermatitis
WEDNESDAY, March 24, 2021 -- For moderate-to-severe atopic dermatitis, the oral Janus kinase 1 (JAK1) inhibitor abrocitinib at 200 mg or 100 mg once daily results in significantly greater reductions in signs and symptoms versus placebo, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2021 Category: Pharmaceuticals Source Type: news

Highlights in Atopic Dermatitis From AAAAI 2021 Highlights in Atopic Dermatitis From AAAAI 2021
Dr Elaine Siegfried discusses highlights in atopic dermatitis from AAAAI 2021: the efficacy of abrocitinib, the impact of COVID-19 on outcomes, and the challenges around food allergy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2021 Category: Consumer Health News Tags: None ReCAP Source Type: news

NIH study of early predictors, mechanisms of food allergy and eczema has begun
(NIH/National Institute of Allergy and Infectious Diseases) A study to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis, or eczema, as well as biological pathways that lead to these conditions, has begun. The observational study of children from birth to age 3 years will examine the origins of allergic disease by integrating interdisciplinary analyses of data from more than 260 biological and environmental samples and survey responses from each of 2,500 families. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2021 Category: International Medicine & Public Health Source Type: news

Bacteriotherapy Passes Early Test in Atopic Dermatitis Study Bacteriotherapy Passes Early Test in Atopic Dermatitis Study
"And perhaps most exciting," Gallo added, is the finding that the subset of patients with AD who were most responsive to the ShA9 compound...showed improvement in...scores used to assess inflammation.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 11, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Soap substitute kills Covid just as well as alcohol sanitiser, study shows
Research, not yet peer-reviewed, shows antimicrobial lotion Dermol 500 neutralises virusCoronavirus – latest updatesSee all our coronavirus coverageIt ’s good news for chapped hands: an antimicrobial soap substitute commonly used by people with dry and itchy skin conditions has been shown to kill coronavirus.Since the start of the pandemic, people with no history of eczema or dermatitis have been developing sore and cracked skin as a result of increased hand-washing or using alcohol sanitiser gel.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 10, 2021 Category: Science Authors: Linda Geddes Tags: Medical research Coronavirus Society Science Health UK news Microbiology Source Type: news

Molecular mechanisms identified in chronic skin inflammation
(Medical University of Vienna) Frequently occurring chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and psoriasis have different causes. A team at MedUni Vienna has now been able to identify new molecular mechanisms as causes that could provide suitable starting points for new therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 5, 2021 Category: International Medicine & Public Health Source Type: news